HomeCompareCNVIF vs ORCC

CNVIF vs ORCC: Dividend Comparison 2026

CNVIF yields 715.82% · ORCC yields 9.79%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CNVIF wins by $1093356.51M in total portfolio value
10 years
CNVIF
CNVIF
● Live price
715.82%
Share price
$0.28
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1093356.53M
Annual income
$857,661,638,708.74
Full CNVIF calculator →
ORCC
ORCC
● Live price
9.79%
Share price
$13.48
Annual div
$1.32
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$1.04
Full ORCC calculator →

Portfolio growth — CNVIF vs ORCC

📍 CNVIF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCNVIFORCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CNVIF + ORCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CNVIF pays
ORCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CNVIF
Annual income on $10K today (after 15% tax)
$60,844.67/yr
After 10yr DRIP, annual income (after tax)
$729,012,392,902.43/yr
ORCC
Annual income on $10K today (after 15% tax)
$832.34/yr
After 10yr DRIP, annual income (after tax)
$0.88/yr
At 15% tax rate, CNVIF beats the other by $729,012,392,901.54/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CNVIF + ORCC for your $10,000?

CNVIF: 50%ORCC: 50%
100% ORCC50/50100% CNVIF
Portfolio after 10yr
$546678.28M
Annual income
$428,830,819,354.89/yr
Blended yield
78.44%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

CNVIF
Analyst Ratings
2
Hold
Consensus: Hold
Altman Z
-31.4
Piotroski
2/9
ORCC
Analyst Ratings
9
Buy
4
Hold
1
Sell
Consensus: Buy
Price Target
$16.00
+18.7% upside vs current
Range: $16.00 — $16.00
Altman Z
0.5
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CNVIF buys
0
ORCC buys
18
PoliticianChamberTickerTypeAmountDate
Trey Hollingsworth🏢 House$ORCC▲ Buy$15,001 - $50,0002022-06-23
Trey Hollingsworth🏢 House$ORCC▲ Buy$250,001 - $500,0002022-06-16
Trey Hollingsworth🏢 House$ORCC▲ Buy$15,001 - $50,0002022-06-14
Trey Hollingsworth🏢 House$ORCC▲ Buy$50,001 - $100,0002022-06-13
Trey Hollingsworth🏢 House$ORCC▲ Buy$50,001 - $100,0002022-06-10
Trey Hollingsworth🏢 House$ORCC▲ Buy$15,001 - $50,0002022-06-09
Trey Hollingsworth🏢 House$ORCC▲ Buy$15,001 - $50,0002022-06-08
Trey Hollingsworth🏢 House$ORCC▲ Buy$50,001 - $100,0002022-06-03
Trey Hollingsworth🏢 House$ORCC▲ Buy$15,001 - $50,0002022-05-24
Trey Hollingsworth🏢 House$ORCC▲ Buy$100,001 - $250,0002022-05-20
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCNVIFORCC
Forward yield715.82%9.79%
Annual dividend / share$2.00$1.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%-50%
Portfolio after 10y$1093356.53M$21.4K
Annual income after 10y$857,661,638,708.74$1.04
Total dividends collected$1074351.08M$1.0K
Payment frequencyquarterlyquarterly
SectorStockBDC
Analyst consensusHoldBuy

Year-by-year: CNVIF vs ORCC ($10,000, DRIP)

YearCNVIF PortfolioCNVIF Income/yrORCC PortfolioORCC Income/yrGap
1← crossover$82,282$71,581.96$11,190$489.61+$71.1KCNVIF
2$638,500$550,458.33$12,229$256.01+$626.3KCNVIF
3$4,675,254$3,992,059.10$13,216$130.74+$4.66MCNVIF
4$32,321,062$27,318,539.92$14,207$66.02+$32.31MCNVIF
5$211,087,354$176,503,817.71$15,234$33.17+$211.07MCNVIF
6$1,303,188,923$1,077,325,454.46$16,317$16.62+$1303.17MCNVIF
7$7,610,373,530$6,215,961,382.17$17,468$8.32+$7610.36MCNVIF
8$42,068,354,877$33,925,255,199.72$18,695$4.16+$42068.34MCNVIF
9$220,275,598,933$175,262,459,214.94$20,006$2.08+$220275.58MCNVIF
10$1,093,356,529,567$857,661,638,708.74$21,407$1.04+$1093356.51MCNVIF

CNVIF vs ORCC: Complete Analysis 2026

CNVIFStock

Conavi Medical Corp. focuses on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. It offers Novasight Hybrid System, a system that combines intravascular ultrasound and optical coherence tomography to enable simultaneous and co-registered imaging of coronary arteries. Conavi Medical Corp. is based in Toronto, Canada.

Full CNVIF Calculator →

ORCCBDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →
📬

Get this CNVIF vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CNVIF vs SCHDCNVIF vs JEPICNVIF vs OCNVIF vs KOCNVIF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.